Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension

WikiDoc Resources for Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Articles
Most recent articles on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Most cited articles on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Review articles on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Articles on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Images of Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Photos of Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Podcasts & MP3s on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Videos on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Evidence Based Medicine
Cochrane Collaboration on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Bandolier on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension TRIP on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Clinical Trials
Ongoing Trials on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension at Clinical Trials.gov Trial results on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Clinical Trials on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension NICE Guidance on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension NHS PRODIGY Guidance FDA on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension CDC on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Books
Books on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
News
Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension in the news Be alerted to news on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension News trends on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Commentary
Blogs on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Definitions
Definitions of Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Patient Resources / Community
Patient resources on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Discussion groups on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Patient Handouts on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Directions to Hospitals Treating Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Risk calculators and risk factors for Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Healthcare Provider Resources
Symptoms of Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Causes & Risk Factors for Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Diagnostic studies for Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension Treatment of Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Continuing Medical Education (CME)
CME Programs on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
International
Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension en Espanol Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension en Francais
Business
Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension in the Marketplace Patents on Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
Experimental / Informatics
List of terms related to Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Complete Title of Study

A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension

Study Acronym (The trial's abbreviation if there is one)

ACCOMPLISH

Principal Investigator, Co-investigators, and Collaborating Institutions

Study Chair: Novartis Pharmaceuticals

Overview of Trial

None reported

Disease State(s) Studied (e.g. acute MI, breast cancer, etc.)

None reported

Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here

None reported

Study Design (e.g. multicenter, randomized, double blind, placebo controlled)

None reported

Study Arms and How They Were Treated (Intervention) (Explanation here)

None reported

Primary Pre-Specified Endpoint

None reported

Secondary Endpoints

None reported

Inclusion Criteria

None reported

Exclusion Criteria

None reported

Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available)

None reported

Conclusions of the Investigators (Quote the investigators conclusions here)

None reported

Commentary, Discussion and Limitations of the Trial (Anyone can add comments)

None reported

Slides

None reported

Video Commentary

None reported

References (How to insert a reference)

None reported

External sites for further information (How to insert links)

None reported

Ages

__ years to ___ years

Gender (Indicate whether men, women or both were enrolled)

None reported

Accepts Healthy Volunteers (Answer yes or no)

None reported

Enrollment Period (Study start and end date)

None reported

Recruitment Status (explanation)

None reported

Enrollment (Total number of patients enrolled)

None reported

Study Sponsor (e.g. Investigator initiated or company name)

None reported (this may not have yet been ascertained)

Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)

None reported

The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.